Cyclooxygenase-2 inhibitors

被引:60
作者
Gajraj, NM [1 ]
机构
[1] UT, SW Med Ctr, Dept Anesthesiol & Pain Management, Eugene McDermott Ctr Pain Management, Dallas, TX USA
关键词
D O I
10.1213/01.ANE.0000061461.55712.C5
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
[No abstract available]
引用
收藏
页码:1720 / 1738
页数:19
相关论文
共 232 条
[11]  
BERTIN P, 2001, EUR LEAG RHEUM EULAR
[12]   Limitation of the in vitro whole blood assay for predicting the COX selectivity of NSAIDs in clinical use [J].
Blain, H ;
Boileau, C ;
Lapicque, F ;
Nédélec, E ;
Loeuille, D ;
Guillaume, C ;
Gaucher, A ;
Jeandel, C ;
Netter, P ;
Jouzeau, JY .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (03) :255-265
[13]   Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. [J].
Bombardier, C ;
Laine, L ;
Reicin, A ;
Shapiro, D ;
Burgos-Vargas, R ;
Davis, B ;
Day, R ;
Ferraz, MB ;
Hawkey, CJ ;
Hochberg, MC ;
Kvien, TK ;
Schnitzer, TJ ;
Weaver, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) :1520-1528
[14]  
Bombardier C, 2002, AM J CARDIOL, V89, p3D
[15]  
Brater D. Craig, 1999, American Journal of Medicine, V107, p65S
[16]   Renal effects of COX-2-selective inhibitors [J].
Brater, DC ;
Harris, C ;
Redfern, JS ;
Gertz, BJ .
AMERICAN JOURNAL OF NEPHROLOGY, 2001, 21 (01) :1-15
[17]   A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors [J].
Brideau, C ;
Kargman, S ;
Liu, S ;
Dallob, AL ;
Ehrich, EW ;
Rodger, IW ;
Chan, CC .
INFLAMMATION RESEARCH, 1996, 45 (02) :68-74
[18]   Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus [J].
Buttar, NS ;
Wang, KK ;
Leontovich, O ;
Westcott, JY ;
Pacifico, RJ ;
Anderson, MA ;
Krishnadath, KK ;
Lutzke, LS ;
Burgart, LJ .
GASTROENTEROLOGY, 2002, 122 (04) :1101-1112
[19]  
BUVANENDRAN A, 2001, ANESTHESIOLOGY, V95, pA868
[20]  
Camu Frederic, 2002, Am J Ther, V9, P43, DOI 10.1097/00045391-200201000-00009